<DOC>
	<DOCNO>NCT02767206</DOCNO>
	<brief_summary>The study aim evaluate feasibility transnasal endoscopy patient portal hypertension , cirrhotic non-cirrhotic . The incidence procedure 's adverse effect , patient 's tolerance his/her opinion exam analyze . In addition , interobserver match discovery find study carry .</brief_summary>
	<brief_title>Evaluation Gastroesophageal Varices Transnasal Endoscopy .</brief_title>
	<detailed_description>It descriptive study proposes evaluate feasibility transnasal endoscopy screen gastroesophageal varix patient portal hypertension , cirrhotic non-cirrhotic . The rupture gastroesophageal varix principal cause death among cirrhotics , responsible high rate morbidity mortality . Current medical literature recommend cirrhotic carrier non-cirrhotic portal hypertension screen gastric-esophageal varix order establish prophylactic therapeutic measure , recommend . Usually , conventional peroral esophagogastroduodenoscopy use purpose need sedation reduces productivity , increase cost introduces small insignificant risk concern complication , especially decompensated cirrhotic . For reason , transnasal endoscopy would interest option patient require sedation . The patient refer endoscopy unit general hepatology viral hepatitis ambulatory setting . All ask undergo esophagogastroduodenoscopy screen gastroesophageal varix invite participate study , long fulfill inclusion criterion agree participate sign Consent Form . After endoscopy , questionnaire fill information exam , tolerance , incidence adverse effect alteration find . This questionnaire information liver disease cause , cirrhosis stag evaluate patient 's disease gravity patient 's perception exam . The endoscopy register alteration find data patient 's monitoring . Besides , alteration related portal hypertension afterwards image analyze another endoscopist photograph matched calculation . The result submit analysis . Statistical difference calculate use test `` '' student Chi-square significant value ( p ) 0.05 consider .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Varicose Veins</mesh_term>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<criteria>The inclusion criterion age ( old 18 ) , clinical , laboratory histologic diagnosis hepatic cirrhosis portal hypertension , agreement participate study . Refusal submit procedure ; refusal inability sign term consent ; previous nasal surgery ; coagulation disturbance consider international normalized ratio 2 , platelet 40,000 ; current use coumarins heparin ; history repetition epistaxis ; allergic rhinitis ; nasal anatomic abnormality know oropharynx ; infection superior aerial duct moment exam .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Transnasal endoscopy</keyword>
	<keyword>ultrathin endoscope</keyword>
	<keyword>esophageal varix</keyword>
	<keyword>gastric varix</keyword>
</DOC>